Home > Insider Trading > Filing (0000880771-16-000195)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
880771	Sciclone Pharmaceuticals Inc	SCLN	Pharmaceutical Preparations (2834)	943116852

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1291656	Wai-Shun Wilson Cheung	950 Tower Lane, Suite 900 Foster City CA 94404	Cfo & Senior Vp, Finance	No	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Acquisiton	2016-10-17	1,005	$5.97	16,609	No	4	M	Direct
Common Stock	Disposition	2016-10-17	1,005	$10.00	15,604	No	4	S	Direct
Common Stock	Disposition	2016-10-17	470	$10.00	15,134	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	M	Direct
No	4	S	Direct
No	4	S	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Non-Qualified Stock Option (right to buy)	Disposition	2016-10-17	1,005	$0.00	1,005	$5.97

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
98,995		2023-08-09	No	4	M	Direct

Footnotes

The reported sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 15, 2016.
Granted under the Issuer's 2005 Equity Incentive Plan.
Provided Reporting Person remains employed by Issuer, the options will vest based upon the successful and timely filing by the SEC filing dates of the 10-Q and 10-Ks for the period from September 30, 2013 through the end of 2014, with the last 10-K filed for the year ending December 31, 2014 by March 16, 2015 (the "Performance Target"). If the Performance Target is not achieved, the options will not vest and will expire on March 17, 2015.